Skip to content
10-Q

Quarterly Report

Oruka Therapeutics, Inc. ORKA

0001213900-24-097443

← back to feed
Filed
Nov 13, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Oct 31, 2024 35M sh
Shares Diluted Q3 2024 · Sep 30, 2024 15.01M sh
Shares Diluted Q3 2024 · Sep 30, 2024 7.77M sh
Cash And Equivalents Q3 2024 · Sep 30, 2024 $410.88M
Current Liabilities Q3 2024 · Sep 30, 2024 $18.04M
Total Liabilities Q3 2024 · Sep 30, 2024 $18.88M
Current Assets Q3 2024 · Sep 30, 2024 $412.95M
Current Assets Q3 2024 · Feb 6, 2024 $1K
Total Assets Q3 2024 · Sep 30, 2024 $414.09M
Total Assets Q3 2024 · Feb 6, 2024 $1K
Eps Diluted Q3 2024 · Sep 30, 2024 −$1.46
Eps Diluted Q3 2024 · Sep 30, 2024 −$6.08
Eps Basic Q3 2024 · Sep 30, 2024 −$1.46
Eps Basic Q3 2024 · Sep 30, 2024 −$6.08
Net Income Q3 2024 · Jun 30, 2024 −$22.24M
Net Income Q3 2024 · Mar 31, 2024 −$7.08M
Stockholders Equity Q3 2024 · Feb 5, 2024 $1K